Quantum Genesis AI Corp. has taken a significant step in its growth strategy by filing an amended offering statement with the SEC. The company aims to raise up to $5 million by offering 500 million shares of common stock at a price of $0.01 each. This move is crucial for the company as it seeks to secure funding to support its operations and potential expansion in the industrial organic chemicals sector.

Founded in 2015 and based in San Diego, California, Quantum Genesis AI Corp. operates under the SIC code 2860, which covers industrial organic chemicals. The company trades on the OTC market under the ticker symbol QGAI. The recent filing, dated October 30, 2026, is an amendment to a previous offering statement, indicating the company's proactive approach to fundraising.

The filing details that this amended offering is classified as a Tier 2 offering under Regulation A. It aims to add the auditor's signature to the report of the independent registered public accounting firm, Fruci & Associates II, PLLC. This step is essential for ensuring compliance with SEC regulations and enhancing investor confidence.

According to the filing, Quantum Genesis AI Corp. has a total of 40,972,050 shares of common stock outstanding. The company has reported total assets of $59,000, with total liabilities amounting to $443,313, resulting in a negative stockholder equity of $443,254. The financials indicate that the company is currently operating at a loss, with a net income of -$24,912.

The offering is expected to attract various investors, particularly those interested in the industrial organic chemicals sector. However, the filing warns that investing in the company's stock involves significant risks, and potential investors should carefully consider these factors before making any decisions.

The offering will not be placed into an escrow account, and the proceeds will be available for use by the company immediately upon acceptance of subscriptions. This approach allows Quantum Genesis AI Corp. to utilize the funds for operational needs without delay.

As the company moves forward with this offering, it will be essential to monitor any subsequent filings or developments. The filing does not specify what happens next, but it indicates a clear intent to advance its fundraising efforts. Investors and market observers will be watching closely to see how this offering impacts Quantum Genesis AI Corp.'s growth trajectory in the competitive landscape of industrial organic chemicals.